If you liked this article you might like

Biotech Sector to See M&A, Earnings Action
Why Bristol-Myers Squibb May Be a Merger Target Soon
Here's Why Johnson & Johnson Shares Are Poised for a Rally
Could Johnson & Johnson Rip Higher by 20%?